Home » Dr. Hans-Joachim Schmoll

Rectal cancer therapy without surgery. Future of Colorectal cancer treatment. 10

Every cancer patient must be evaluated by Tumor Board. Multidisciplinary Team. 9-2

Quality of treatment of colorectal cancer varies greatly. 9-1

Liquid biopsy in colorectal cancer. Precision diagnosis and treatment. 8-2

Colorectal cancer prognosis. Adaptive clinical trials. Prediction of response to treatment. 8-1

Stage 4 colon cancer. Liver or lung metastases. Locoregional treatment. DEBIRI TACE, IRE, SIRT. 7

Colorectal cancer chemotherapy in elderly. Choose treatment based on fitness. 6

Chemotherapy of rectal cancer. Capecitabine (Xeloda) and oxaliplatin 5-FU. Controversies. 5-3

Capecitabine (Xeloda) therapy efficacy prediction. DPD enzyme gene expression in colon cancer. 5-2

Stage 3 colon cancer treatment. Capecitabine (Xeloda) and 5-Fluorouracil (5-FU). 5-1

Treatment of colorectal cancer with HER2 inhibitors. Herceptin and Lapatinib (Tykerb). 4-2

Precision chemotherapy of colorectal cancer. EGFR, BRAF, MEK inhibitors. 4-1

Colorectal cancer immunotherapy. Which patients benefit most? 3-2

Colorectal cancer stem cells. Immunotherapy of colon cancer. 3-1

Precision treatment of colon cancer. Patient’s genetic profile is important. 2-2

Staging of colorectal cancer. Molecular cancer classification for precision treatment of tumors. 2-1

Colon cancer screening. Which test is most effective? Tumor DNA tests from feces and blood. Part 2 of 2. 1-2

Colon cancer screening. Which test is most effective? Part 1 of 2. Colonoscopy. 1-1

Dr. Hans-Joachim Schmoll. Colorectal cancer expert. Biography. 0